The Scientist : BRCA2 patent upheld [1/7/2005]

Supplements

Survey Series

The Scientist Daily

Science headlines delivered daily.
Register today.

For Advertisers

by Grit Kienzlen

NEWS ANALYSIS

BRCA2 patent upheld

Email: Grit Kienzlen - grit.kienzlen@web.de
News from The Scientist 2005, 6(1):20050701-01

Published

1 July 2005

The European Patent Office (EPO) this week upheld a patent owned by Utah-based biotech firm Myriad Genetics for breast cancer susceptibility testing related to a particular BRCA2 mutation, despite opposition from geneticists who said the patent discriminated against Ashkenazi Jews.

Password

> Forgot Password?
> FAQ
> Subscribe

Subscribing to The Scientist is easy and inexpensive.

And you can choose from many options. Try us out with an online day pass starting at only $4.95. Or, get it all with unlimited online access to The Scientist Archive and door-to-door delivery of our monthly print magazine.


	The Scientist also offers site licenses to institutions and organizations. When your librarian adds The Scientist to the library's collection, you can get unlimited online access through your place of work or study. Recommend The Scientist today